Keros Therapeutics, Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

14.41

+0.45 (3.22%)

At close: Aug 14, 2025, 4:00 PM

14.42

+0.01 (0.07%)

After-hours: Aug 14, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2021	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Therapeutics for Hematological, Pulmonary and Cardiovascular Disorders	3.55M	Log In	Log In	Log In	Log In
Therapeutics for Hematological, Pulmonary and Cardiovascular Disorders Growth	2250.99%	Log In	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2021	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	3.55M	Log In	Log In	Log In	Log In
United States Growth	2250.99%	Log In	Log In	Log In	Log In